tr-anzgog

ANZGOG Member, Professor Anna De Fazio-Poidevin awarded Member of the Order of Australia on Australia Day

ANZGOG Member Prof Anna De Fazio - Poidevin has been appointed a Member of the Order of Australia in the Australia Day list which was announced by the Governor-General today, January 26. Prof De Fazio [...]

ANZGOG Member, Professor Anna De Fazio-Poidevin awarded Member of the Order of Australia on Australia Day2023-10-18T11:58:36+11:00

Dr Jeffrey Goh explains ITTACc – ANZGOG’s latest cervical cancer study

ITTACc is ANZGOG’s phase II, randomised multi-centre non-comparative trial of sitravatinib in recurrent or metastatic cervical cancer that have progressed after standard therapies. ANZGOG spoke with ITTACc Principal Investigator, Dr Jeffrey Goh, who explained the study [...]

Dr Jeffrey Goh explains ITTACc – ANZGOG’s latest cervical cancer study2023-10-18T12:05:35+11:00

Guidelines for cellular and molecular pathology content in clinical trial protocols published

The SPIRIT-Path guidelines for the inclusion of pathology in clinical trial protocols have been published in The Lancet Oncology. Prof Anna DeFazio, Chair TR-ANZGOG Steering Committee The SPIRIT-Path extension guidelines were developed [...]

Guidelines for cellular and molecular pathology content in clinical trial protocols published2021-10-07T05:58:12+11:00

TR-ANZGOG launches – ANZGOG’s exciting translational research initiative

Translational ANZGOG, ‘TR-ANZGOG’, is an exciting ANZGOG research initiative established to achieve a 2015 ANZGOG Strategic Goal: “World-class translational research in gynaecological cancers”. TR-ANZGOG Steering Committee Chair, Professor Anna DeFazio and TR-ANZGOG Project Manager, Claire [...]

TR-ANZGOG launches – ANZGOG’s exciting translational research initiative2021-02-10T04:24:10+11:00
Go to Top